[Development of inhibitor against hemophilia and prevention and management strategies forpatients with hemophilia].
Run-hui
RH
Wu
Qi-qi
QQ
Wei
D019774:Blood Coagulation Factor Inhibitors / Q000037:antagonists & inhibitors* / Q000097:blood; D005169:Factor VIII / Q000008:administration & dosage* / Q000037:antagonists & inhibitors / Q000276:immunology*; D006467:Hemophilia A / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D007518:Isoantibodies / Q000097:blood / Q000276:immunology; D011994:Recombinant Proteins / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D012307:Risk Factors; D013997:Time Factors
D019774:Blood Coagulation Factor Inhibitors; D007518:Isoantibodies; D011994:Recombinant Proteins; D005169:Factor VIII